Pre-exposure prophylaxis (PrEP) against HIV using antiretrovirals is now approved for adults at high risk, but an alarming proportion of new infections now occur among youth. Research establishing the benefits of PrEP has included few young people, these authors point out, and they may be the ones who need it most urgently.
RESULT: Pre-Exposure Prophylaxis (PrEP) for Adolescents and Young Adults at Risk for HIV Infection: Is an Ounce of Prevention Worth a Pound of Cure?
Clinical Infectious Diseases | Dec 7, 2012 (Free abstract. Full text $40)
This recent review offers all the basic information primary care providers need about offering PrEP and monitoring patients who receive it. The article includes information about identifying persons most likely to benefit from PrEP, and about counseling and monitoring, as well as discussing issues related to cost and insurance. Adolescents, however, are not discussed.
RESULT: What Primary Care Providers Need to Know About Preexposure Prophylaxis for HIV Prevention: A Narrative Review
Annals of Internal Medicine | Oct 2, 2012 (FREE FULL TEXT)